Success Story: EB2 NIW Approval for a Biophysics and Physical Chemistry Postdoctoral Fellow in 81 days
On April 15th, 2013, we received another EB2 NIW (National Interest Waiver) Approval for a Postdoctoral Fellow in the field of Biophysics and Physical Chemistry (Approval Notice)
General Field: Biophysics and Physical Chemistry
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Russia
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: April 15, 2013
Processing Time: 81 days
Client’s Testimonial:
Thank you so much!
It was a pleasure working with you, the process was really seamless and almost effortless.
Case Summary:
This client is a postdoctoral fellow from Russia with a specialization in biophysics and physical chemistry. Specifically, his research focuses on the study of protein folding and allosteric regulation, as well as cytoskeletal dynamics for the study of filopoida. He wished to continue his research on the mechanisms of certain diseases, such as Alzheimer’s, amyloidosis, mad cow disease, and certain cancers, at the prestigious university institute for which he works. To ensure successful approval of this case, we submitted extensive documentationof the client’s highlysignificant contributions to the field of physics and chemistry, including his authorship on ten peer-reviewed scientific articles published in leading journals, 1 book chapter and 12conference presentations. The client’s publications often appeared first in Google Scholar database search using various keywords Additionally, our firm drafted and submitted several recommendation letters from experts in our client’s shared field. One of the independent recommenders noted “[The petitioner’s] computational program is more than ten times faster than any previous technology. His method is now relied on by scientists working to advance protein knowledge.” With the strong petition letter and recommendation letters we prepared, , his NIW was able to be processed with ease, and was approved in under 3 months.